Here are relevant reports on : bioinformatics-market
-
Defibrillator Market by Product (Implantable Cardioverter Defibrillator, External Defibrillator (Automated Defibrillator, Wearable Defibrillator, Manual Defibrillator)), End User (Hospitals & Clinics, Cardiac Centers, Homecare) - Global Forecast to 2030
The global defibrillator market, valued at US$11.29 billion in 2024, stood at US$11.99 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$16.44 billion by the end of the period. Major players in the defibrillator market include Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Nihon Kohden Corporation (Japan), Biotronik (Germany), and CU Medical Systems, Inc. (South Korea).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Mobile Medical Applications & Social media for Health Market- Global Trends, Opportunities and Forecasts till 2017
Mobile applications or apps and smartphones are used in various areas of healthcare such as health education, data management, health management, work flow process, health information, etc. The healthcare industry demonstrated a relevant requisite for using mobile technology to assist its processes, so as to make health information access and support available almost everywhere that a mobile phone can go. Medical community is using smartphones and their applications for basic work at a higher rate than the general population, and is also using them for reporting in replacement for work that was previously done on a desktop or laptop computer.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Wireless Health Market by Technology (WPAN, WLAN/Wifi, WiMAX), Component (Hardware, Software, & Services), Application (Patient Specific and Provider/Payer Specific), & by End Users (Providers, & Payers) - Global Forecast to 2020
The global Wireless Health Market size is projected to grow at a CAGR of 23.1%. The market is segmented on the basis of technologies, components, applications, and end users. The market is expected to be dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period.
- Published: March 2016
- Price: $ 4950
- TOC Available:
-
eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Operation, Analytics), Trial Phase, End User (CRO, Pharma, Biotech, Medtech), Regulatory, AI, Growth, Market Size - Forecast to 2030
The global eclinical solutions market, valued at US$11.62 billion in 2024, stood at US$13.18 billion in 2025 and is projected to advance at a resilient CAGR of 13.9% from 2025 to 2030, culminating in a forecasted valuation of US$25.22 billion by the end of the period. The market is driven by the increasing adoption of digital technologies to improve clinical trial efficiency, data accuracy, and regulatory compliance.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) & Geography - Global Forecast to 2022
The clinical laboratory services market is expected to reach USD 146.41 billion by 2022 from USD 113.4 billion in 2017, at a CAGR of 5.2% during the forecast period. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others
- Published: December 2017
- Price: $ 4950
- TOC Available:
-
Outlook of Cardiac Pacemaker Market - Global Forecasts (2011-2016)
Pacemaker devices constitute a major segment in a rapidly expanding cardiovascular devices market. The global cardiac pacemakers market is characterized by relatively mature conditions and intense competition. However, an aging global population, and the subsequent rise in the incidence of cardiovascular diseases, has ensured a steady growth for the pacemakers market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Erectile Dysfunction, Premature Ejaculation & Alopecia Market - Global Forecasts (2011-2016)
The development of erectile dysfunction is associated with an underlying cause which is organic in nature. Drug induced causes of erectile dysfunction are common and can complicate the medical management of underlying conditions such as hypertension, depression, and BPH. Beta blockers, selective serotonin reuptake inhibitors (SSRIs), and the uroselective alpha adrenergic receptor antagonists have been associated with the loss of libido or ejaculatory disorders, which can result in drug discontinuation by patients and suboptimal treatment of these conditions.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Cell Culture Market by Product (Consumables (Media, Sera, Reagent, Vessels (Roller bottle, Flask, Cell Factory)), Equipment (Bioreactors, Centrifuges, Filtration, Incubators, Freezers)), Application (mAbs, Vaccines, CGT), End User - Global Forecast to 2030
The global cell culture market, valued at US$27.92 billion in 2024, stood at US$29.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$50.69 billion by the end of the period. Growing opportunities in emerging economies and advancements in 2D and 3D cell culture technology is likely to offer potential growth opportunities in the cell culture market.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
SNP (Single Nucleotide Polymorphism) Market: Genotyping and Analysis, Future of SNPs in Personalized Medicine (2011-2016)
SNP (Single Nucleotide Polymorphism) genotyping is a measurement of genetic variations. It is the most common type of genetic variation between humans. Specific single base pair mutations are ideal for identifying correlation between genotype and human behavior.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Global Biological Implants Market (2011-2016)
Biological Implants find enormous application in the fields of neurological, cardiovascular, vascular, urogenital, nephrological and orthopedic systems. They are used to treat various disorders of the above systems. Biological Implants are expected to increase productivity by identifying potential biological substitutes for the body’s repairable parts. Currently United States serves as the largest market for these biological implants. The biological implants market is segmented by Tissue/Muscle into Soft Tissue, Orthopedic, Cardiovascular, Other (includes Dental, Ophthalmic, and Urologic). By Origin these implants are segmented as Allograft and Xenograft, and by Mode of Administration into Injectable and Surgical.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
